StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report released on Friday. The firm issued a hold rating on the stock.
Milestone Scientific Stock Performance
MLSS stock opened at $0.66 on Friday. The firm has a 50 day moving average of $0.70 and a 200-day moving average of $0.66. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35. The firm has a market capitalization of $50.89 million, a P/E ratio of -6.59 and a beta of 0.89.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its quarterly earnings data on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The firm had revenue of $2.25 million during the quarter.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- What Are Dividends? Buy the Best Dividend Stocks
- Don’t Miss These Stock Picks for the Lumber Price Surge
- The How and Why of Investing in Gold Stocks
- NVIDIA Stock Defies Skeptics, Earns Analyst Upgrade
- Breakout Stocks: What They Are and How to Identify Them
- 3 Highly Profitable Companies Set for Double-Digit Upside
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
